Spectrum Pharmaceuticals, Inc., has announced the approval of its Abbreviated New Drug Application (ANDA) for carboplatin injection in 50-, 150-, and 450-mg multidose vials from the FDA’s Office of Generic Drugs. Carboplatin is a platinum-based, anti-cancer drug used in the treatment of patients with various tumor types. Paraplatin® is marketed by Bristol-Myers Squibb.
canadian cialis online
In April, Spectrum entered into an alliance with Cura Pharmaceuticals Co., Inc., to market and distribute carboplatin injection in the U.S.